导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 51.64% | 51/1050 |
| 近一周 | 1.49% | 143/1104 |
| 近一月 | -2.03% | 362/1103 |
| 近一季 | -9.24% | 665/1092 |
| 近半年 | 41.93% | 39/1070 |
| 近一年 | 59.82% | 60/1018 |
| 近两年 | 197.05% | 68/926 |
| 近三年 | 118.33% | 78/834 |
| 成立以来 | 80.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.22% 187/1070 |
96.72% 59/1101 |
- - |
- - |
| 2025 | 47.86% 214/1065 |
12.60% 85/1014 |
4.48% 327/1038 |
23.21% 505/1050 |
2.01% 305/1065 |
| 2024 | 0.99% 551/1011 |
-9.78% 764/960 |
-2.30% 458/983 |
7.59% 795/991 |
6.48% 103/1011 |
| 2023 | -8.71% 289/952 |
6.99% 224/880 |
0.26% 174/895 |
-12.29% 691/915 |
-2.98% 328/952 |
| 2022 | -30.75% 647/867 |
-25.85% 725/773 |
14.34% 136/806 |
-15.79% 610/845 |
-3.00% 578/867 |
| 2021 | -15.83% 521/740 |
-7.22% 426/580 |
11.49% 318/659 |
-14.81% 606/704 |
-4.49% 583/740 |
| 2020 | 55.70% 213/554 |
1.04% 134/419 |
37.26% 46/466 |
3.11% 386/517 |
8.89% 380/554 |
| 2019 | 67.63% 48/410 |
31.00% 318/1146 |
-2.22% 535/1228 |
14.69% 42/390 |
14.11% 68/410 |
| 2018 | - - |
- - |
- - |
-7.29% 603/1000 |
-11.06% 396/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 广发科技动力股票 VS. 东吴新产业精选股票A(580008) |